DuPont stock trades below fair value as earnings growth story builds

DuPont de Nemours Inc. (US26614N1028) stock is trading below several fair-value estimates even as projections point to strong earnings growth for 2026, giving investors a numbers-driven contrast between price and fundamentals as of August 19, 2026.

Recent market data as of August 18, 2026 shows DuPont de Nemours shares at $138.81, reflecting short-term weakness despite a higher longer-term fair-value narrative that sets an indicative value of $172.07 per share in the same comparison framework.

A separate market snapshot for the Cboe listing of DuPont de Nemours on August 19, 2026 reports a real-time price of $139.78, a gain of 0.71% over the prior five trading days and a decline of 3.84% since the start of the year, highlighting that the current quote remains some distance below those fair-value estimates.

DuPont stock valuation gap

The gap between DuPont de Nemours stock price and valuation models is visible in current market commentary that sets a fair-value figure of $172.07 per share against a spot price of $138.81, a discount of $33.26 that equates to roughly 24% below the implied value at that time.

This same commentary notes that the shares have experienced short-term weakness in the prior week, but the valuation framework still points to upside relative to the prevailing trading level, suggesting that for investors the tension between price performance and earnings expectations is central to the current DuPont story.

Market data from the Cboe-centered quote page underlines that, even after a modest five-day gain of 0.71%, DuPont de Nemours remains down 3.84% for the year to August 19, 2026, so the stock has not yet tracked the stronger underlying growth narrative that some projections assign to the company.

Earnings growth expectations

Current industry outlook commentary assigns DuPont a projected earnings growth rate of 44.3% for 2026, placing the company among peers with significant expected improvements in profitability based on the latest consensus figures.

This 44.3% projected earnings growth for 2026 is a forward-looking metric that, while not yet validated by reported results, serves as a key input to valuation models that anchor the $172.07 fair-value figure and help explain why DuPont de Nemours stock is discussed as undervalued at current prices.

Against the year-to-date share-price decline of 3.84% reported on the Cboe quote page as of August 19, 2026, the contrast between negative price momentum and double-digit projected earnings expansion is stark, reinforcing the narrative that the market has not fully priced in the expected improvement in DuPont's earnings profile.

Investors evaluating DuPont de Nemours thus face a situation where a discounted price, a specific fair-value target, and a quantified earnings growth expectation can all be assessed together, offering a clear numerical framework rather than a purely qualitative outlook.

Market context and performance

The broader market backdrop reinforces the relevance of DuPont's valuation discussion, with major US equity indices showing volatility yet recent support from falling Treasury yields and shifting expectations for government bond buybacks, factors that can influence industrial and materials stocks like DuPont de Nemours.

In this context, DuPont's five-day price gain of 0.71% as of August 19, 2026 may be seen as a tentative stabilization rather than a decisive trend change, particularly when measured against the longer horizon in which the shares remain down 3.84% since the start of the year on the same Cboe-linked data.

Given the fair value indication of $172.07, the current range between roughly $138.81 and $139.78 across different quote snapshots suggests that DuPont de Nemours stock has traded in a band that remains clearly below valuation models that incorporate the projected 44.3% earnings growth rate for 2026.

For investors, this numerical spread between fair value and market price is a central point: the combination of a documented discount, a specific growth rate expectation, and a modest recent recovery provides a fact-based lens through which to consider DuPont's risk-reward profile without resorting to generic sentiment-driven language.

Representative product and business angle

DuPont de Nemours is widely recognized for its portfolio of engineered materials and specialty products used across transportation, electronics, construction, and industrial applications, and while the current valuation narrative focuses on earnings and price, the underlying business remains grounded in these demand drivers.

One representative area of DuPont's offering is high-performance materials used in automotive and industrial components, where durability and specialized chemical properties create recurring demand from manufacturers, underpinning revenue streams that feed into the earnings growth projections highlighted for 2026.

Another important product cluster lies in advanced polymers and films, which serve sectors ranging from consumer electronics to packaging, and contribute to the diversification of DuPont's revenue base, a factor that often supports resilience in earnings across different economic cycles.

Investors who look beyond short-term price fluctuations therefore see DuPont de Nemours as a company whose engineered materials portfolio generates cash flows that, if they match or exceed the projected 44.3% earnings growth for 2026, could help close the current valuation gap identified between trading price and fair-value estimates.

Closing stock perspective

As of August 19, 2026, the most recent real-time quote for DuPont de Nemours on the Cboe listing indicates a price of $139.78, showing a five-day gain of 0.71% and a year-to-date decline of 3.84%, a concise snapshot of market performance that frames the broader valuation and growth discussion.

This pricing context, combined with the forward 44.3% earnings growth projection and the $172.07 fair-value indication, means DuPont stock currently sits at a discount to implied value while carrying a clear numerical growth narrative, a mix that investors can quantify on both the price and fundamental sides.